You are here

Journal of Diabetes Science and Technology

Journal of Diabetes Science and Technology

Published in Association with Diabetes Technology Society

eISSN: 19322968 | ISSN: 19322968 | Current volume: 15 | Current issue: 4 Frequency: Bi-monthly
The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.

Journal of Diabetes Science and Technology (DST) is a bi-monthly, peer-reviewed scientific e-journal published by the Diabetes Technology Society, a non-profit organization. Our purpose is to promote the development and adoption of new products to help people with diabetes.

JDST covers all aspects of diabetes technology including: glucose monitoring; insulin and metabolic peptide delivery; the artificial and bioartificial pancreas, telemedicine; software for modeling; physiologic monitoring; technology for managing obesity; diagnostic tests of glycation; and the use of bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors and actuators to be applied to diabetes. Articles in DST will cover both basic research and clinical applications of technologies being developed to help people with diabetes.

JDST’s Editors, Editorial Board, Clinical Advisory Board, and staff aim to provide members of the diabetes technology community with information about the latest scientific and medical advances, as well as news of professional meetings and business developments in the field of diabetes technology. The importance of diabetes technology is increasing for the 200 million diabetes patients worldwide. JDST is a virtual meeting place for members of the diabetes technology community who: believe that technology can deliver great benefits to people with diabetes; want to read about what their peers are doing; and want to communicate with each other via Letters to the Editor, a type of format which will facilitate quick responses to posted letters.

JDST publishes Original Articles, Review Articles, Commentary Articles, Analysis Articles, Letters to the Editor, Proceedings of Diabetes Meetings, and regular columns devoted to business developments and the scientific and medical literature. The journal website provides the latest news stories and timely references from the medical literature.

JDST is the only journal that publishes the proceedings of the Diabetes Technology Meeting and the Clinical Diabetes Technology Meeting, as well as other diabetes meetings.

Those who subscribe to this electronic journal will have complete access to our News Section which includes the latest developments in research and business, plus important government announcements.

We at JDST hope you will find this journal informative, provocative, and even entertaining.

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Medical Center, San Mateo, California, USA
Managing Editor
Lutz Heinemann, PhD Science & Co. Dusseldorf, Germany
Associate Editors
Claudio Cobelli, PhD University of Padova, Italy
Gerold M. Grodsky, PhD University of California at San Francisco, USA
Boris Kovatchev, PhD University of Virginia, USA
Bijan Najafi, PhD Baylor College of Medicine, USA
Production Editor
Annamarie Sucher-Jones Diabetes Technology Society, USA
Associate Production Editor
Kevin Nguyen Diabetes Technology Society, USA
Editorial Board
Mark A. Arnold, PhD University of Iowa, USA
Eirik Arsand, PhD Norwegian Centre for Integrated Care and Telemedicine, Norway
Katharine Barnard-Kelly, PhD BHR Ltd, Portsmouth, Hampshire, UK
Yael Barr, MD NASA Johnson Space Center, USA
Riccardo Bellazzi, PhD University of Pavia, Italy
B. Wayne Bequette, PhD Rensselaer Polytechnic Institute, USA
Richard N. Bergman, PhD Cedars-Sinai Medical Center, USA
Robert D. Burk, MD Albert Einstein College of Medicine, USA
Jessica R. Castle, MD Oregon Health & Science University, Portland, OR, USA
George Cembrowski, MD, PhD University of Alberta, Canada
Geoffrey Chase, PhD University of Canterbury, New Zealand
Kong Chen, PhD NIDDK, National Institutes of Health, USA
Chiara Dalla Man, PhD University of Padova, Italy
Erik Dutson, MD University of California Los Angeles, USA
Niels Ejskaer, MD, PhD Aalborg University Hospital, North Jutland, Denmark
G. Alexander Fleming, MD Kinexum, USA
Thomas Forst, MD University of Mainz, Germany
Karl E. Friedl, PhD University of California at San Francisco, USA
Brian Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas) The Queen's Medical Research Institute, University of Edinburgh, UK
Robert Gabbay, MD, PhD American Diabetes Association, Boston, Massachusetts, USA
Michael S. German, MD University of California at San Francisco, San Francisco, USA
Barry H. Ginsberg, MD, PhD Diabetes Technology Consultants, Arlington, Virginia, USA
Andrei Gribok, PhD United States Department of Agriculture, USA
Alberto Gutierrez, PhD NDA Partners LLC, USA
Jeffrey I. Joseph, DO Thomas Jefferson University, USA
Robert Langer, ScD Massachusetts Institute of Technology, USA
Courtney H. Lias, PhD Food and Drug Administration, Silver Spring, MD, USA
Dorian Liepmann, PhD University of California at Berkeley, USA
Randie R. Little, PhD University of Missouri, USA
Boris Mankovsky, MD National Medical Academy for Postgraduate Education, Ukraine
Chhavi Mehta, M.D. Palo Alto Medical Foundation, USA
Sultan Ayoub Meo, MBBS, M Med Ed, PhD, FRCP College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia
V. Mohan, MD, FRCP, PhD, DSc, FNASc Madras Diabetes Research Foundation, India
Shelagh Mulvaney, PhD Vanderbilt University, USA
Danny Petrasek, MD, PhD California Institute of Technology, USA
John Pickup, MD, PhD Guy’s King’s & St. Thomas’ School of Medicine, UK
Leonard Pogach, MD VA New Jersey Healthcare System, USA
Bruce Quinn, MD, JD Bruce Quinn Associaties LLC, Los Angeles and Palo Alto, California, USA
Sohi Rastegar, PhD National Science Foundation, USA
David Rodbard, MD Biomedical Informatics Consultants LLC, Potomac, Maryland, USA
Jane Jeffrie Seley, DNP, MPH, MSN, BC-ADM, CDE New York Presbyterian/Weill Cornell, USA
James Shapiro, MD, PhD, FRCS(Eng), FRCSC, MSM, FCAHS University of Alberta, Edmonton, Canada
Koji Sode, PhD The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Jeffrey Sutton, MD, PhD Baylor College of Medicine Houston, Texas, USA
Mark True, MD San Antonio Uniformed Services Health Education Consortium, Fort Sam Houston, Texas, USA
Elissa R. Weitzman, ScD, Msc Harvard Medical School, Boston Children’s Hospital, USA
Darrell Wilson, MD Stanford University, USA
  • ProQuest
  • PubMed
  • PubMed: MEDLINE
  • Guidelines for Submitting a Manuscript

    View the Manuscript Submission Guidelines here.

    After reading the guidelines, please submit to the manuscript central site

    All authors need to add their ORCID iDs in Manuscript Central prior to acceptance in order for the IDs to be published on the final article, if accepted. If your manuscript is accepted for publication, you will not be able to add an ORCID iD after the manuscript is sent to our production team.

    JDST authors have the option to make their articles open access via SAGE Choice for $3,000. Learn more about SAGE Choice

    JDST authors may fast track their articles to publication by paying the journal’s Fast Track fee of $3,000. Please contact our journal staff if you are interested in the Fast Track option upon submission.

    Topics of Interest
    Journal of Diabetes Science and Technology (DST) welcomes the submission of manuscripts with accompanying figures and tables whose topics relate to the study and treatment of diabetes:

    • Glucose monitoring
    • Insulin and metabolic peptide delivery
    • Artificial and bioartificial pancreas
    • Information technology
    • Telemedicine
    • Software for modeling
    • Physiologic monitoring
    • Technology for managing obesity
    • Diagnostic tests of glycation
    • Personalized medicine for diabetes, including pharmacogenomics and biomarkers
    • Technology for improving adherence to therapy
    • Use of bioengineered tools such as
    • MEMS
    • New biomaterials
    • Nanotechnology in the development of sensors and actuators

    Journal of Diabetes Science and Technology features articles that cover basic research and clinical applications of technology that are being developed to help people with diabetes. The journal is also committed to delivering high quality, fast peer-review for your paper.

    "Thanks for your fast turnaround. This is actually one of the main reasons why I choose DST instead of other journals"
    - Anonymous author


    Sage Choice

    If you or your funder wish your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.


    Individual Subscription, E-access

    Institutional Subscription, E-access

    ePlatform, Single Issue 24 hour E-access